PPARA and liver cancer: Results from studies examining the mechanism of PPARα-dependent liver cancer also show that activation of this receptor effectively decreases serum lipids in both rodents and humans, but the changes in the let7c pathway occur only in wild-type mice, which is not found in PPARA-humanized mice after chronic treatment with either Wy-14,643 or GW7647 [13,14,16].